Can turmeric powder treat asthma in children?
Phase 2
Completed
- Conditions
- Persistent asthma
- Registration Number
- RBR-9f3wwp
- Lead Sponsor
- Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Children between 7 and 18 years; with a diagnostic of persistent asthma, mild, moderate or severe, controlled or not.
Exclusion Criteria
Allergy to C. longa; parental request; failure to adhere to the treatment.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expected: Reduction of , classification of disease control , after 12 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.;Observed: Reduction of , classification of disease control , after 6 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.
- Secondary Outcome Measures
Name Time Method Expected: Decrease in , forced expiration volume in 1 second (FEV1) , after 12 months , of at least 10% , assessed by pulmonary lung function test (spirometry).;Observed: Decrease in , frequency of nighttime awakenings , after 6 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.;Observed: Decrease in , frequency of use of short-acting beta-adrenergic agonists , after 6 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of curcumin in Curcuma longa L. may influence Th2 cytokine pathways in pediatric asthma?
How does turmeric powder compare to inhaled corticosteroids in controlling persistent asthma in children?
Are there specific biomarkers like FeNO or IL-4 that could predict response to Curcuma longa L. in asthma patients?
What are the potential adverse events of Curcuma longa L. administration in children and how are they managed?
What combination therapies involving curcuminoids show promise in treating persistent asthma compared to monotherapy?